Published in FEMS Immunol Med Microbiol on July 01, 2009
Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One (2010) 1.75
Additive function of Vibrio vulnificus MARTX(Vv) and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS Pathog (2012) 1.18
Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest (2010) 1.06
Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging. Gut Microbes (2011) 1.02
Vibrio cholerae ToxR downregulates virulence factor production in response to cyclo(Phe-Pro). MBio (2013) 0.88
Development of a Fur-dependent and tightly regulated expression system in Escherichia coli for toxic protein synthesis. BMC Biotechnol (2013) 0.86
Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment. Infect Immun (2011) 0.80
Vibrio cholerae leuO Transcription Is Positively Regulated by ToxR and Contributes to Bile Resistance. J Bacteriol (2015) 0.79
Substrate-dependent activation of the Vibrio cholerae vexAB RND efflux system requires vexR. PLoS One (2015) 0.79
Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo. Infect Immun (2014) 0.78
Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization. Vet Microbiol (2016) 0.75
Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev (1986) 5.79
Host-induced epidemic spread of the cholera bacterium. Nature (2002) 5.20
Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol (1998) 3.24
Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae. Mol Microbiol (2002) 3.09
Selection for in vivo regulators of bacterial virulence. Proc Natl Acad Sci U S A (2001) 2.98
Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science (2004) 2.58
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun (2006) 2.07
Metabolic load and heterologous gene expression. Biotechnol Adv (1995) 2.05
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis (1992) 1.94
Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe (2007) 1.90
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine (1990) 1.87
Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun (2005) 1.78
Iron and fur regulation in Vibrio cholerae and the role of fur in virulence. Infect Immun (2005) 1.73
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc Natl Acad Sci U S A (2003) 1.60
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett (2004) 1.59
Effects of DNase production, plasmid size, and restriction barriers on transformation of Vibrio cholerae by electroporation and osmotic shock. FEMS Microbiol Lett (1990) 1.46
Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol (2001) 1.45
An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. Proc Natl Acad Sci U S A (2007) 1.38
Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. Infect Immun (2005) 1.37
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun (1992) 1.35
Identification of an operon required for ferrichrome iron utilization in Vibrio cholerae. J Bacteriol (2000) 1.30
The suckling mouse model of cholera. Trends Microbiol (2000) 1.29
Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc (2008) 1.22
Development of a germfree mouse model of Vibrio cholerae infection. Infect Immun (1996) 1.22
Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun (1997) 1.22
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol (2007) 1.16
Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun (2006) 1.08
Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses. Infect Immun (2001) 1.04
In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect Immun (2000) 1.02
Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infect Immun (1992) 1.01
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect Immun (2001) 1.01
Bacterial luciferase activity and the intracellular redox pool in Escherichia coli. Mol Genet Genomics (2005) 1.00
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine (1996) 0.99
Proteomic analysis of Vibrio cholerae in human stool. Infect Immun (2008) 0.97
Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect Immun (2003) 0.95
Bioluminescence imaging to evaluate infections and host response in vivo. Methods Mol Biol (2008) 0.92
A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect Immun (1998) 0.90
IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine (2000) 0.89
Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect Immun (2003) 0.88
The ompU Paralogue vca1008 is required for virulence of Vibrio cholerae. J Bacteriol (2004) 0.87
Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. J Biotechnol (2006) 0.86
Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors. Infect Immun (2008) 0.85
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects. Dev Biol Stand (1995) 0.84
Exploiting cholera vaccines as a versatile antigen delivery platform. Biotechnol Lett (2007) 0.79
Bacteria-host communication: the language of hormones. Proc Natl Acad Sci U S A (2003) 4.38
Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol Microbiol (2002) 3.48
Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol (2003) 3.35
The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol Microbiol (2002) 2.75
Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect Immun (2002) 2.18
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells. Infect Immun (2003) 1.97
StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol Microbiol (2002) 1.92
Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun (2005) 1.89
Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. Infect Immun (2002) 1.88
Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci U S A (2007) 1.80
Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli. Environ Microbiol (2009) 1.65
Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect Immun (2003) 1.49
Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo. Infect Immun (2004) 1.44
Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. FEMS Microbiol Lett (2004) 1.43
Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection. Infect Immun (2005) 1.41
Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol (2005) 1.40
Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest (2007) 1.39
An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. Proc Natl Acad Sci U S A (2007) 1.38
SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun (2005) 1.32
Characterization of Cah, a calcium-binding and heat-extractable autotransporter protein of enterohaemorrhagic Escherichia coli. Mol Microbiol (2002) 1.32
Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol (2006) 1.29
Pathogenic Escherichia coli. Int J Med Microbiol (2005) 1.26
Etiology of acute diarrhea in adults in southwestern Nigeria. J Clin Microbiol (2003) 1.21
Long polar fimbriae and tissue tropism in Escherichia coli O157:H7. Microbes Infect (2006) 1.20
The N-terminus of enteropathogenic Escherichia coli (EPEC) Tir mediates transport across bacterial and eukaryotic cell membranes. Mol Microbiol (2002) 1.19
Nucleotide sequence analysis of the enteropathogenic Escherichia coli adherence factor plasmid pMAR7. Infect Immun (2006) 1.19
SepL, a protein required for enteropathogenic Escherichia coli type III translocation, interacts with secretion component SepD. Mol Microbiol (2004) 1.17
A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF. Infect Immun (2002) 1.15
The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli. J Bacteriol (2009) 1.13
Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun (2004) 1.12
Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol (2009) 1.08
ToxR interferes with CRP-dependent transcriptional activation of ompT in Vibrio cholerae. Mol Microbiol (2002) 1.07
Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation. Infect Immun (2008) 1.07
Genetic diversity of the gene cluster encoding longus, a type IV pilus of enterotoxigenic Escherichia coli. J Bacteriol (2007) 1.05
The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol (2008) 1.05
Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging. Gut Microbes (2011) 1.02
Identification and characterization of the locus for diffuse adherence, which encodes a novel afimbrial adhesin found in atypical enteropathogenic Escherichia coli. Infect Immun (2005) 1.01
Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2. Infect Immun (2010) 1.01
Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2. Infect Immun (2007) 0.99
Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98
Fitness cost of the green fluorescent protein in gastrointestinal bacteria. Can J Microbiol (2003) 0.98
Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect (2006) 0.96
Post-transcriptional processing of the LEE4 operon in enterohaemorrhagic Escherichia coli. Mol Microbiol (2008) 0.96
The Escherichia coli phosphotyrosine proteome relates to core pathways and virulence. PLoS Pathog (2013) 0.94
The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E. coli O157:H7. Environ Microbiol (2009) 0.93
The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium. Infect Immun (2006) 0.93
Induction of interleukin-8 in T84 cells by Vibrio cholerae. Infect Immun (2004) 0.89
Antibiotic-resistant cell-detaching Escherichia coli strains from Nigerian children. J Clin Microbiol (2002) 0.86
The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli. Vet Microbiol (2007) 0.85
The LysR-type transcriptional regulator QseD alters type three secretion in enterohemorrhagic Escherichia coli and motility in K-12 Escherichia coli. J Bacteriol (2010) 0.85
In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection. BMC Microbiol (2012) 0.85
Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr Nephrol (2002) 0.84
Identification and characterization of "pathoadaptive mutations" of the cadBA operon in several intestinal Escherichia coli. Int J Med Microbiol (2006) 0.82
Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium. PLoS One (2013) 0.82
Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural populations in southern Ontario. J Infect Dis (2003) 0.82
The ribosome binding site of a mini-ORF protects a T3SS mRNA from degradation by RNase E. Mol Microbiol (2012) 0.81
Functional analysis of the enteropathogenic Escherichia coli type III secretion system chaperone CesT identifies domains that mediate substrate interactions. Mol Microbiol (2002) 0.81
Colonization of gnotobiotic piglets by a luxS mutant strain of Escherichia coli O157:H7. Infect Immun (2005) 0.81
Contribution of urease to colonization by Shiga toxin-producing Escherichia coli. Infect Immun (2012) 0.81
Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo. PLoS One (2012) 0.80
Functional and phylogenetic analysis of ureD in Shiga toxin-producing Escherichia coli. J Bacteriol (2010) 0.79
Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. Microb Pathog (2009) 0.78
Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae. Infect Immun (2004) 0.77